ANDREW BROOKS, PhD
CHAIRMAN OF THE SCIENTIFIC ADVISORY BOARD
Andrew is the Chief Operating Officer of RUCDR Infinite Biologics (RUCDR) at Rutgers University, the world’s largest academic biorepository managing critical biological resources for clients such as The National Institute of Health, leading academic researchers, and major pharmaceutical and biotechnology companies.
Additionally, Andrew is the Chief Scientist for TMRW’s infrastructure partner, Brooks Life Sciences, a division of the $2 billion (NASDAQ) Brooks Corporation.
Andrew is also a Professor of Medicine and Genetics at Rutgers University. He is trained in molecular neuroscience and gene therapy and is widely recognized as a thought leader in the field of personalized medicine.
Andrew has deep experience in advising leading US, global institutions, and governments on health policy, including serving on the boards and scientific leadership of several global biorepository and precision medicine programs in Europe, Qatar, and Australia.